Why Corcept Therapeutics Inc (NASDAQ:CORT) Stock climbed 17.51% in Last Three Months?
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
Corcept Therapeutics Inc (NASDAQ:CORT) Stock Price Slipped -2.24% to $23.97
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
Growing at an Unbelievable Rate: Corcept Therapeutics Inc (CORT) Stock
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
The performance of Corcept Therapeutics Inc (CORT) Stock has improved
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
Corcept Therapeutics Inc (CORT) Stock Is Looking Attractive
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
A healthy upside potential exists for Corcept Therapeutics Inc (CORT) Stock
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
